Literature DB >> 29460225

The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.

David C Perlman1,2, Ashly E Jordan3,4.   

Abstract

PURPOSE OF REVIEW: This article reviews the case for recognizing (1) the epidemics of opioid misuse, overdose, hepatitis C virus, and HIV as a syndemic and (2) the importance of examining and addressing structural factors in responses to this syndemic. We focus on the current syndemic in the US, but also consider data from other locations to highlight the issues existing and arising in various contexts. RECENT
FINDINGS: Advances in multi-level theory and statistical methods allow sound ecologic and multi-level analyses of the impact of structural factors on the syndemic. Studies of opioid misuse, overdoses, hepatitis C virus, and HIV demonstrate that area-level access to healthcare, medication-assisted treatment of opioid use disorders, sterile injection equipment, and overdose prevention with naloxone, as well as factors such as opioid marketing, income inequality, intensity of policing activities, and health care policies, are related to the prevalence of substance misuse, overdoses, infection risk, and morbidity. Structural variables can predict area-level vulnerability to the syndemic. The implementation of combined prevention and treatment interventions can control and reverse components of the syndemic. Recognizing and monitoring potent structural factors can facilitate the identification of areas at risk of vulnerability to the syndemic. Further, many structural factors are modifiable through intervention and policy to reduce structural vulnerability and create health-enabling environments. Evidence supports the immediate implementation of broader HCV and HIV testing and substance use screening, medication-assisted treatment, needle/syringe exchange programs, naloxone programs, increased population-level implementation of HCV treatment, and further attention to structural-level factors predicting, and contributing to, area-level vulnerability, such as degrees of opioid marketing, distribution, and prescribing.

Entities:  

Keywords:  HIV; Hepatitis C virus; Opioid use disorders; Opioids; Overdose; Structural determinants of health

Mesh:

Year:  2018        PMID: 29460225      PMCID: PMC5884743          DOI: 10.1007/s11904-018-0390-3

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  90 in total

Review 1.  The social determinants of health: coming of age.

Authors:  Paula Braveman; Susan Egerter; David R Williams
Journal:  Annu Rev Public Health       Date:  2011       Impact factor: 21.981

2.  Hepatitis C Direct Acting Antiviral Therapies in a New York City HIV/AIDS Special Needs Plan: Uptake and Barriers.

Authors:  Mark H Kuniholm; Terry Leach; Joseph Lunievicz; Noemí Olivo; Kathryn Anastos; Yvette Vazquez; Mark Brennan-Ing; Stephen E Karpiak; Oladipo Alao; Denis Nash; Jerome Ernst
Journal:  AIDS Patient Care STDS       Date:  2015-12       Impact factor: 5.078

3.  "There's nothing here": Deindustrialization as risk environment for overdose.

Authors:  Katherine McLean
Journal:  Int J Drug Policy       Date:  2016-01-18

Review 4.  Addressing social drivers of HIV/AIDS for the long-term response: conceptual and methodological considerations.

Authors:  Judith D Auerbach; Justin O Parkhurst; Carlos F Cáceres
Journal:  Glob Public Health       Date:  2011-07-11

5.  Evolving trade policy and the Trans-Pacific Partnership Agreement: does it threaten Vietnam's access to medicine and its progress towards scaling up HIV prevention, treatment and care?

Authors:  Nguyen Nhat Linh; Nguyen Thanh Huong; Hua Thanh Thuy
Journal:  Glob Public Health       Date:  2014-12-03

6.  Effects of the great recession on drugs consumption in Spain.

Authors:  Nicolau Martin Bassols; Judit Vall Castelló
Journal:  Econ Hum Biol       Date:  2016-03-19       Impact factor: 2.184

7.  Tennessee's In-state Vulnerability Assessment for a "Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection" Event Utilizing Data About the Opioid Epidemic.

Authors:  Michael Rickles; Peter F Rebeiro; Lindsey Sizemore; Paul Juarez; Mitchell Mutter; Carolyn Wester; Melissa McPheeters
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

Review 8.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

9.  Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2012-11-09

10.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

View more
  48 in total

Review 1.  The United States opioid epidemic.

Authors:  Jennifer Lyden; Ingrid A Binswanger
Journal:  Semin Perinatol       Date:  2019-01-14       Impact factor: 3.300

2.  A joint spatial model of opioid-associated deaths and treatment admissions in Ohio.

Authors:  David Kline; Staci Hepler; Andrea Bonny; Erin McKnight
Journal:  Ann Epidemiol       Date:  2019-03-12       Impact factor: 3.797

Review 3.  A Review of Interventions to Enhance HIV Medication Adherence.

Authors:  Laura B Whiteley; Elizabeth M Olsen; Kayla K Haubrick; Enyonam Odoom; Nicholas Tarantino; Larry K Brown
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-21       Impact factor: 5.071

4.  Patient-centred care in opioid agonist treatment could improve outcomes.

Authors:  Thomas D Brothers; Matthew Bonn
Journal:  CMAJ       Date:  2019-04-29       Impact factor: 8.262

5.  Characteristics Associated with Nonmedical Methadone Use among People Who Inject Drugs in California.

Authors:  Johnathan K Zhao; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2019-10-14       Impact factor: 2.164

6.  Sexual Orientation Disparities in Prescription Opioid Misuse Among U.S. Adults.

Authors:  Dustin T Duncan; Sophia Zweig; H Rhodes Hambrick; Joseph J Palamar
Journal:  Am J Prev Med       Date:  2018-11-19       Impact factor: 5.043

7.  Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.

Authors:  Ashly E Jordan; Charles M Cleland; Katarzyna Wyka; Bruce R Schackman; David C Perlman; Denis Nash
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

8.  The protective effect of trusted dealers against opioid overdose in the U.S.

Authors:  Jennifer J Carroll; Josiah D Rich; Traci C Green
Journal:  Int J Drug Policy       Date:  2020-03-04

9.  Estimating the burden of the opioid epidemic for adults and adolescents in Ohio counties.

Authors:  David Kline; Staci A Hepler
Journal:  Biometrics       Date:  2020-06-02       Impact factor: 2.571

10.  Prescription opiate analgesics, heroin, HIV and HCV among persons who inject drugs in New York City, 2016-2018.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; David C Perlman; Susan Tross
Journal:  Drug Alcohol Depend       Date:  2019-08-30       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.